<DOC>
	<DOCNO>NCT01956513</DOCNO>
	<brief_summary>The main objective study assess sensitivity specificity variation apparent diffusion coefficient prediction , course neoadjuvant chemotherapy modification treatment sequence , pathological response end chemotherapy</brief_summary>
	<brief_title>Contribution MRI Evaluation Apparent Diffusion Coefficient Prediction Response Neoadjuvant Chemotherapy Breast Cancer</brief_title>
	<detailed_description />
	<criteria>Age &gt; 18 year . Patient suffer breast tumor , regardless stage size Patient require neoadjuvant chemotherapy Patient ability undergo 18FFDGPET baseline , end cycle 1 end neoadjuvant treatment surgery Compulsory affiliation social security system . Obtaining informed consent writing , sign date . Patient cognitive psychiatric disorder . Patient deprive liberty court administrative . Patient sign achievement MRI , mammography ultrasound Patient metastatic Patient prior chemotherapy , radiotherapy hormone therapy breast cancer Pregnant woman , current lactation Patient suffering uncontrolled diabetes ( &gt; 11 mmol / L )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>ADC</keyword>
	<keyword>breast cancer</keyword>
	<keyword>complete pathological response</keyword>
</DOC>